MedTrace Logo

Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex

NCT01828385 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-01-21

No results posted yet for this study

Summary

The aim of this study is to determine the recovery time of moderate neuromuscular blockade with sugammadex in adults pretreated with magnesium sulfate.

Conditions

  • Neuromuscular Blockade

Interventions

DRUG

Magnesium Sulfate

Magnesium sulfate + rocuronium + sugammadex

DRUG

Saline

Saline + rocuronium + sugammadex

Sponsors & Collaborators

  • Hospital Federal de Bonsucesso

    collaborator OTHER

  • Universidade Federal do Rio de Janeiro

    lead OTHER

Principal Investigators

  • Paulo A Germano Filho, MD · Hospital Federal de Bonsucesso

  • Núbia V Figueiredo, PhD · Universidade Federal do Rio de Janeiro

  • Ismar L Cavalcanti, PhD · Universidade Federal do Rio de Janeiro

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01828385 on ClinicalTrials.gov